Skip to content

Treatment of obstructive sleep apnea hypopnea syndrome with subtotal glossectomy

Treatment of obstructive sleep apnea hypopnea syndrome with subtotal glossectomy

Status
Recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2000035235
Enrollment
Unknown
Registered
2020-08-04
Start date
2020-08-01
Completion date
Unknown
Last updated
2020-08-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Obstructive sleep apnea hypopnea syndrome

Interventions

experimental group:subtotal glossectomy
control group:PAP

Sponsors

Beijing Luhe Hospital, Capital Medical University
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: (1) 18-60 years old, gender unlimited; (2) Patients with moderate or severe OSAHS (AHI > 15 times / hour) were diagnosed by PSG monitoring; (3) Failure, intolerance or rejection of ventilator and oral appliance treatment; (4) Electronic laryngoscopy and oropharyngeal CT scan were used to evaluate whether the occlusive plane was consistent with that of glossopharyngeal plane; (5) Friedman grade II or above, TCM score 17 or above; (6) It can accept the possible complications, sequelae.

Exclusion criteria

Exclusion criteria: (1) The patients with poor general condition and severe cardiovascular and cerebrovascular diseases can not tolerate general anesthesia. (2) The head and face bone deformity or abnormality that seriously affects the airway. (3) Sleep disorders caused by pregnancy, hypothyroidism, acromegaly and other endocrine disorders. (4) Severe obesity, BMI > 40 kg / m2. (5) People who are addicted to drugs or alcohol or have mental disorders that are difficult to control. (6) Those who do not meet the expectation of the surgical effect. (7) The person who is mentally retarded or immature and whose behavior cannot be controlled.

Design outcomes

Primary

MeasureTime frame
Apnea hypopnea index (AHI);

Secondary

MeasureTime frame
Adverse events;

Countries

China

Contacts

Public ContactZhixuan Liu

Beijing Luhe Hospital, Capital Medical University

lzx1999@163.com+86 13911558743

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026